Scientists used a bacterial system called retron to turn DNA into a programmable tool inside living cells, enabling gene regulation and disease detection. The non-genetic DNA platform leverages a ...

India, April 13 -- Life Biosciences, a clinical-stage biotechnology company focused on reversing diseases of aging, has ...

Storm Therapeutics raises $56M in Series C funding to accelerate cancer therapy development and expand its innovative ...

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

Endogenous Retroviruses (ERVs), relics from ancient viral infections, form a significant part of vertebrate genomes, including humans, where they constitute ...

Mayo Clinic Comprehensive Cancer Center scientists, physicians and trainees will present nearly 60 studies on emerging cancer therapies, diagnostics and prevention strategies at the 2026 American ...

Scientists at the Salk Institute for Biological Studies and Sanford Burnham Prebys explore genetic factors in separate papers ...

Drug development is aiming to move from managing disease to correcting it through RNA and gene-editing therapies. But ...

Cloning from the clone of a clone of a clone may not be the ingenious idea we thought it was.

What happened next may become the most important medical story of the decade. In just six months, a team at Children’s ...

Most gene-editing tools are blind to context. Point them at a DNA sequence and they cut, whether that sequence sits inside a ...

Creative Biogene is proud to announce the launch of its innovative iPSC RNA reprogramming products, specifically designed to enhance the efficiency and safety of iPSC generation.